Results 31 to 40 of about 134,564 (250)

Consensus Guidelines for the Treatment of Infectious Endocarditis with Outpatient Parenteral Antibiotic Therapy

open access: yesCanadian Journal of Infectious Diseases, 2000
The development of single, daily dose antibiotic regimens and the availability of computerized ambulatory infusion pumps have made it possible for most patients with infectious endocarditis (IE) to complete their treatment in an outpatient setting.
Shurjeel H Choudhri   +1 more
doaj   +1 more source

RVOT mural and mitral valve endocarditis: A case report

open access: yesIndian Heart Journal, 2015
Mural endocarditis is a very rare condition. This entity involves bacterial growth on cardiac walls. In addition, concomitant valvular endocarditis, along with mural endocarditis, is an extremely rare combination.
Maadh Jawad, Shaun Cardozo
doaj   +1 more source

Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß   +14 more
wiley   +1 more source

Broad-Host-Range Shuttle Vectors for Screening of Regulated Promoter Activity in Viridans Group Streptococci: Isolation of a pH-Regulated Promoter [PDF]

open access: yes, 2000
Viridans group streptococci are major constituents of the normal human oral flora and are also identified as the predominant pathogenic bacteria in native valve infective endocarditis.
Zaat, S. A.   +20 more
core   +2 more sources

Interventional Mitral Valve Edge‐to‐Edge Repair in Patients Above 85 Years of Age

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Mitral valve transcatheter‐edge‐to‐edge repair (M‐TEER) is routinely performed in patients with severe mitral regurgitation (MR) at high operative risk, frequently including elderly patients. Patients ≥ 85 years, however, are frequently excluded in clinical studies.
Florian Jürgens   +8 more
wiley   +1 more source

Clinical features of the course of infective endocarditis of prosthetic valves and endocarditis of intracardiac devices

open access: yesЛечащий Врач
Background. The increase in the number of cardiac surgeries has also led to a growth in cases of infective endocarditis of prosthetic valves and intracardiac devices.
V. A. Mosina   +6 more
doaj   +1 more source

Successful Percutaneous Retrieval of an Embolized MitraClip From the Right Subclavian Artery

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Single leaflet device attachment (SLDA) after mitral transcatheter valve edge‐to‐edge repair (M‐TEER) has been reported in up to 5% of patients. However, complete embolization of the M‐TEER device is exceedingly rare. Device retrievals in all previously reported cases were completed by vascular surgery cut down at the end. In this case, we are
Seyed Hossein Aalaei‐Andabili   +2 more
wiley   +1 more source

Current Challenges in the Management of Infective Endocarditis

open access: yesFrontiers in Medicine, 2021
Infective endocarditis is a relatively rare, but deadly cause of sepsis, with an overall mortality ranging from 20 to 25% in most series. Although the classic clinical classification into syndromes of acute or subacute endocarditis have not completely ...
Guillermo Cuervo   +7 more
doaj   +1 more source

Diagnosis of infective endocarditis with cardiac CT in an adult

open access: yesRadiology Case Reports, 2019
The diagnosis of infective endocarditis is based on modified Duke's criteria, which includes clinical, biological, and echocardiographic findings. However, computed tomography (CT) has not been mentioned as a diagnostic tool in the criteria.
Kotaro Ouchi, MD, PhD   +6 more
doaj   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy